Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: a prospective population-based study.

Journal: BMJ mental health

Volume: 27

Issue: 1

Year of Publication: 2024

Affiliated Institutions:  Population-based Cohorts Unit, Paris Saclay University, Paris, France baptistepignon@yahoo.fr. Population-based Cohorts Unit, Paris Saclay University, Paris, France. Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. Sorbonne Université, Inserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Paris, France. Université Paris-Saclay, UVSQ, INSERM, CESP U, Gustave Roussy, Villejuif, France. Sorbonne Paris Nord University, Inserm U, Inrae U, Cnam, Nutritional Epidemiology Research Team (EREN), Centre of Research in Epidemiology and Statistics (CRESS) - Université Paris Cité (CRESS), Bobigny, France. Service de Psychiatrie de l'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, France. Université Paris Cité, VIFASOM (Vigilance Fatigue Sommeil et Santé Publique), Paris, France. Université Paris Cité, Service de Médecine interne, AP-HP, Hôpital européen Georges-Pompidou, Paris, France. Université Paris Cité, INSERM U, Institut de Psychiatrie et Neuroscience de Paris, Paris, France.

Abstract summary 

Identifying factors that predict the course of persistent symptoms that occurred during the COVID-19 pandemic is a public health issue. Modifiable factors could be targeted in therapeutic interventions.This prospective study based on the population-based CONSTANCES cohort examined whether the psychological burden associated with incident persistent symptoms (ie, that first occurred from March 2020) would predict having ≥1 persistent symptom 6-10 months later.A total of 8424 participants (mean age=54.6 years (SD=12.6), 57.2% women) having ≥1 incident persistent symptom at baseline (ie, between December 2020 and February 2021) were included. The psychological burden associated with these persistent symptoms was assessed with the Somatic Symptom Disorder-B Criteria Scale (SSD-12). The outcome was having ≥1 persistent symptom at follow-up. Adjusted binary logistic regression models examined the association between the SSD-12 score and the outcome.At follow-up, 1124 participants (13.3%) still had ≥1 persistent symptom. The SSD-12 score at baseline was associated with persistent symptoms at follow-up in both participants with (OR (95% CI) for one IQR increase: 1.42 (1.09 to 1.84)) and without SARS-CoV-2 infection prior to baseline (1.39 (1.25 to 1.55)). Female gender, older age, poorer self-rated health and infection prior to baseline were also associated with persistent symptoms at follow-up.The psychological burden associated with persistent symptoms at baseline predicted the presence of ≥1 persistent symptom at follow-up regardless of infection prior to baseline.Intervention studies should test whether reducing the psychological burden associated with persistent symptoms could improve the course of these symptoms.

Authors & Co-authors:  Pignon Matta Wiernik Toussaint Loewe Robineau Carrat Severi Touvier Gouraud Ouazana Vedrines Pitron Ranque Hoertel Kab Goldberg Zins Lemogne

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  18
Identifiers
Doi : e300907
SSN : 2755-9734
Study Population
Female
Mesh Terms
Humans
Other Terms
COVID-19
Study Design
Study Approach
Country of Study
Publication Country
England